Health
1,000 UK doctors condemn medical association’s push to lift puberty blocker ban for minors
From LifeSiteNews
1,000 senior doctors signed an open letter to the British Medical Association after it lobbied for the NHS to lift a ban on puberty blockers for children following the Cass Review, which found the drugs were harmful.
On August 1, the British Medical Association (BMA) – the United Kingdom’s doctors’ union – called on the government to lift the ban on puberty blockers for minors. Weirdly, the BMA also stated that in their view the implementation of NHS England’s Cass Review should be “paused” despite the fact that, as the BBC noted, the review “took four years to carry out and was widely welcomed by the medical establishment in the U.K.” The BMA called the Cass Review’s recommendations – based on “the largest and most comprehensive review” on the subject seen, looking at 237 papers from 18 countries – “unsubstantiated.”
A spokesperson for the Department of Health and Social Care responded to the BMA, firmly rejecting both the request and the claim, stating, “The Cass Review is a robust report backed by clinicians and firmly grounded in evidence. NHS England will be implementing Dr. Cass’s recommendations so that children and young people get the safe, holistic support they need. We do not support a delay to vital improvements from the NHS to gender services.” Even the leftist Guardian ran an editorial criticizing the BMA’s position, stating, “The BMA’s stance on puberty blockers defies the key principle of medicine: first, do no harm.”
READ: FDA official recommends approval of puberty blockers despite suicide risk for gender-confused youth
As it turns out, there are plenty of physicians who are very unhappy with the BMA’s move – and they are now making their voices heard. This week, 1,000 senior doctors from across the U.K. published an open letter addressed to Professor Philip Banfield, chairman of the BMA.
“We write as doctors to say, ‘not in my name,’” the letter reads. “We are extremely disappointed that the BMA council had passed a motion to conduct a ‘critique’ of the Cass Review and to lobby to oppose its recommendations. The passing of the motion was opaque and secretive. It does not reflect the views of the wider membership, whose opinion you did not seek. We understand that no information will be released on the voting figures and how council members voted. That is a failure of accountability to members and is simply not acceptable.”
The open letter further emphasizes that the Cass Review “is the most comprehensive review into healthcare for children with gender related distress ever conducted” and urged the BMA to “abandon its pointless exercise” of attacking and opposing the recommendations. “By lobbying against the best evidence we have, the BMA is going against the principles of evidence-based medicine and against ethical practice.”
Among the signatories to the letter are 23 former or current clinical leaders at royal colleges, as well as the heads and former heads of some royal colleges.
The British Medical Association is the only main medical organization to oppose the Cass Review; all others have backed it. For example, Professor Sir Stephen Powis, NHS national medical director, stated, “These plans set out in detail how we will establish a fundamentally different and safer model of care for children and young people. The work Dr. Cass has undertaken has been invaluable in helping us shape the new service offer, and we have already begun our transformation of these services by opening two new regional centres this year.” Banfield responded on behalf of the BMA council to say that the points made in the letter would be considered during their ongoing evaluation.
As Josephine Bartosch observed, “it is becoming increasingly clear that the BMA is dangerously out of step with the medical consensus. The Cass Review has sent ripples across the world, and from lawsuits in the U.S. to a change of tack across Europe – medics are increasingly acknowledging that what is a crisis in youth mental health cannot be cured by changing bodies.”
From LifeSiteNews
The family of an elderly man is speaking out about the terrible hospital conditions that led their father to request euthanasia before he died of natural causes.
The family of Cleo Gratton, an 84-year-old retired diamond driller who died earlier this month in Chelmsford, Ontario, of natural causes after being approved for assisted suicide, is speaking publicly about their appalling experience in the Canadian healthcare system.
According to the CBC, the elderly man “told his family he would rather die than go back to Health Sciences North in Sudbury,” and that a recent stay there found Gratton, who was suffering from heart disease and kidney failure, spending one night in the emergency room and then being transferred to a bed sitting in the hallway on the seventh floor.
“There were no lights, all the bulbs in that hallway had been completely removed,” his daughter, Lynn, told the CBC. “The only light we had was almost like a desk lamp that had been bolted to the wall. Patients are passing by, nurses are going by, no privacy, no compassion, no dignity.” The visit took place in mid-October, after which Gratton decided to apply for “medical aid in dying,” or assisted suicide.
Lynn said that nurses had to use headlamps to inspect her father’s feet, and that the experience was “just one thing after another and it really opened our eyes to what’s going on in our hospitals. My dad said, ‘Push, push, push for change. Make people aware of what’s gong on. Open the discussion, bring it to your MP, your MPP, keep going straight up.”
His family is now honoring his wishes to speak out about his experience. The doctors and nurses, Lynn emphasized, were “amazing,” but she noted that they seem overworked. “Why are they still taking in patients if we have an overcrowding issue and they have no place to put these people?” she said.
Cleo Gratton, who died of natural causes surrounded by his family before he could go through with assisted suicide, is just the most recent of many examples of Canadians opting for assisted suicide because they could not access the care that they actually desired.
In Quebec last year, Norman Meunier, a quadriplegic man, developed bedsores after four days left on an ER stretcher without a good mattress. That experience combined with lack of available homecare pushed him to request, and receive, assisted suicide.
An unnamed woman in her 80s, referred to in a MAID report as “Mrs. B,” received MAID earlier this year after requesting but being denied palliative or hospice care. Instead, with her spouse burning out as the result of her care, a rushed MAID assessment was completed, and she died by lethal injection.
In 2022, 44-year-old Winnipeg woman Sathya Dhara Khovac died by euthanasia after failing to receive the homecare resources she had desperately sought. In her posthumous obituary, she said she could have had more time if she’d had more help.
In 2019, 41-year-old Sean Tagert was euthanized after spending years attempting to find and fund the homecare and resources he needed to stay in the community where his son lived. He did not want to die but felt that he had no other choice.
And, among other stories, at least four Canadian veterans were offered assisted suicide in lieu of the unavailable mental health supports they were requesting.
Stories of Canadians seeking palliative care, mental health resources, homecare, and other medical support finding that the only option available to them is assisted suicide have become routine over the past several years. Euthanasia has become a pressure valve for an overworked and under-funded healthcare system serving an aging population increasingly need of complex care — and if assisted suicide for mental illness is legalize, things will get much, much worse.
Dr John Campbell
Cures for Cancer? A new study shows incredible results from cheap generic drug Fenbendazole
From Dr. John Campbell
You won’t hear much about Fenbendazole from the regular pipeline of medical information. There could be many reasons for that. For one, it’s primarily known for it’s use in veterinary medicine. Somehow during COVID the medical information pipeline convinced millions that if a drug is used on horses or other animals it couldn’t work for humans. Not sure how they got away with that one considering the use of animal trials for much of modern medical history.
Another possible reason, one that makes at least as much sense, is that there’s no business case for Fenbendazole. It’s been around for decades and its patent expired in the early 1990’s. That means it’s considered a generic drug that a pharmaceutical company from India could (and does) produce in mass quantities for very little profit (compared to non-generics).
So Fenbendazole is an inexpensive, widely accessible antiparasitic drug used in veterinary medicine. During the COVID pandemic a number of doctors, desperate for a suitable treatment, tried it with reportedly great levels of success. Over some time they discovered it might be useful elsewhere. Some doctors are using Fenbendazole to help treat late stage cancer. Often this is prescribed when the regular treatments clearly aren’t working and cancer is approaching or has already been declared stage 4.
What they’ve found at least in some cases is astounding results. This has resulted in a new study which medical researcher Dr. John Campbell shares in this video.
It should not take a crisis for Canada to develop the resources that make people and communities thrive.
Federal budget: It’s not easy being green
Courts and governments caused B.C.’s property crisis—they’re not about to fix it
Richmond Mayor Warns Property Owners That The Cowichan Case Puts Their Titles At Risk
-
Health2 days ago
Lack of adequate health care pushing Canadians toward assisted suicide
-
National2 days agoWatchdog Demands Answers as MP Chris d’Entremont Crosses Floor
-
Business1 day agoLiberal’s green spending putting Canada on a road to ruin
-
Media2 days agoBreaking News: the public actually expects journalists to determine the truth of statements they report
-
Artificial Intelligence2 days agoAI seems fairly impressed by Pierre Poilievre’s ability to communicate
-
Alberta11 hours agoAlberta Offers Enormous Advantages for AI Data Centres
-
Alberta2 days agoATA Collect $72 Million in Dues But Couldn’t Pay Striking Teachers a Dime
-
Business1 day agoCarney doubles down on NET ZERO